The liquid form of the flu drug Tamiflu is in short supply because of early strong demand.But the shortage is expected to be brief, lasting only through mid-January, according to its manufacturer, Genentech. Doctors typically give the ...
Tags: Tamiflu, Tamiflu Shortage, Health News
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS® for oral suspension, a new pediatric formulation of Merck's integrase ...
Tags: Merck, ISENTRESS®, oral suspension, pediatric formulation
The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
Merck has secured priority review status from the US Food and Drug Administration (FDA) for its new drug application (NDA) for an investigational intravenous (IV) solution formulation of its antifungal agent, Noxafil (posaconazole), ...
Lundbeck, a Denmark-based pharmaceutical company, has obtained the US Food and Drug Administration (FDA) approval for its SABRIL (vigabatrin), an adjunctive treatment option for children 10 and older with refractory complex partial ...
Mylan Pharmaceuticals, a subsidiary of Mylan, has introduced Voriconazole for oral suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for oral suspension. The US Food and Drug Administration (FDA) has granted a ...
Tags: Mylan, Antifungal Drug
Danish drugmaker Lundbeck has announced the availability of ONFI (clobazam) in scored tablet and oral suspension formulations in the US pharmacies beginning this week. ONFI, an oral anti-epileptic drug (AED) of the benzodiazepine class, ...
Aurobindo Pharma has gained final FDA approval for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral ...
Tags: Aurobindo Pharma, FDA, Nevirapine, HIV drug
Lupin Pharmaceuticals has obtained FDA approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL and anticipates initiating product shipment shortly. Suprax oral suspension is indicated for otitis media, acute exacerbation of chronic ...
Tags: Lupin Pharmaceuticals, FDA, Suprax
Pfizer has announced the availability of attention deficit hyperactivity disorder (ADHD) therapy, Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension, in the US. The extended-release liquid ...
Tags: Pfizer, ADHD therapy, Quillivant XR CII
Pfizer has announced the completion of its purchase of a specialty pharmaceutical company NextWave Pharmaceuticals. Through the acquisition,Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant ...
Tags: Pfizer, specialty pharmaceutical company, NextWave Pharmaceuticals